LU-177 PSMA

Clinical trials for LU-177 PSMA explained in plain language.

Never miss a new study

Get alerted when new LU-177 PSMA trials appear

Sign up with your email to follow new studies for LU-177 PSMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New safety study for prostate cancer drug in vulnerable patients

Disease control Not yet recruiting

This study aims to measure how much radiation from Pluvicto therapy reaches tumors and healthy organs in prostate cancer patients whose kidneys or bone marrow aren't working properly. Researchers will track 25 patients to understand the safety and side effects of this treatment i…

Matched conditions: LU-177 PSMA

Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

LU-177 PSMA

Get alerted when new LU-177 PSMA trials appear

New safety study for prostate cancer drug in vulnerable patients